Search details
1.
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.
Gastric Cancer
; 16(3): 411-9, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23065042
2.
Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study.
Gastric Cancer
; 15(4): 419-26, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22237659
3.
HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer.
Histopathology
; 58(5): 669-78, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21447133
4.
Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer.
J Clin Oncol
; 29(36): 4789-95, 2011 Dec 20.
Article
in English
| MEDLINE | ID: mdl-22042954
5.
Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.
Pharmacogenomics
; 11(9): 1247-56, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20860465
6.
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.
Eur J Cancer
; 44(13): 1875-82, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18617393
Results
1 -
6
de 6
1
Next >
>>